Press Releases 3 Investor Relations Press Releases Events Presentations Press Releases Year None2022202120202019201820172016 May 18, 2022 DermTech Presents New Research Differentiating Atopic Dermatitis and Psoriasis at the Society for Investigative Dermatology’s Annual Meeting May 10, 2022 DermTech Reinforces Longstanding Mission to Help Reduce Melanoma Deaths, Aligning with the Biden Administration’s Renewed ‘Cancer Moonshot’ Program May 04, 2022 DermTech Kicks Off Second Annual #Stickit2Melanoma Campaign, Raising Awareness for Melanoma and the Importance of Skin Exams May 03, 2022 DermTech Reports First-Quarter 2022 Financial Results; Company Affirms Full-Year 2022 Outlook Apr 28, 2022 DermTech Announces Publication of New GvHD Clinical Research Conducted in Collaboration with Memorial Sloan Kettering Cancer Center Apr 26, 2022 DermTech Expands Telehealth Application, DermTech Connect, Across 44 States Apr 25, 2022 DermTech to Showcase DermTech Stratum, an Expanded Translational Medicine Service Offering, at San Diego’s Inaugural ‘Innovation Day’ Event Apr 14, 2022 DermTech Announces Release Date for First-Quarter 2022 Financial Results Mar 28, 2022 DermTech Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Mar 08, 2022 DermTech Study, “Cost-Benefit Analysis of the Pigmented Lesion Assay When Introduced into the Visual Assessment / Histopathology Pathway for Lesions Clinically Suspicious for Melanoma,” Published in SKIN: The Journal of Cutaneous Medicine Pagination Current page 1 Page 2 Next page next › Last page last » Displaying 1 - 10 of 15 Investor Tools Print Email Page Email Alerts RSS Feeds Contact IR
Press Releases Year None2022202120202019201820172016 May 18, 2022 DermTech Presents New Research Differentiating Atopic Dermatitis and Psoriasis at the Society for Investigative Dermatology’s Annual Meeting May 10, 2022 DermTech Reinforces Longstanding Mission to Help Reduce Melanoma Deaths, Aligning with the Biden Administration’s Renewed ‘Cancer Moonshot’ Program May 04, 2022 DermTech Kicks Off Second Annual #Stickit2Melanoma Campaign, Raising Awareness for Melanoma and the Importance of Skin Exams May 03, 2022 DermTech Reports First-Quarter 2022 Financial Results; Company Affirms Full-Year 2022 Outlook Apr 28, 2022 DermTech Announces Publication of New GvHD Clinical Research Conducted in Collaboration with Memorial Sloan Kettering Cancer Center Apr 26, 2022 DermTech Expands Telehealth Application, DermTech Connect, Across 44 States Apr 25, 2022 DermTech to Showcase DermTech Stratum, an Expanded Translational Medicine Service Offering, at San Diego’s Inaugural ‘Innovation Day’ Event Apr 14, 2022 DermTech Announces Release Date for First-Quarter 2022 Financial Results Mar 28, 2022 DermTech Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Mar 08, 2022 DermTech Study, “Cost-Benefit Analysis of the Pigmented Lesion Assay When Introduced into the Visual Assessment / Histopathology Pathway for Lesions Clinically Suspicious for Melanoma,” Published in SKIN: The Journal of Cutaneous Medicine Pagination Current page 1 Page 2 Next page next › Last page last » Displaying 1 - 10 of 15
May 18, 2022 DermTech Presents New Research Differentiating Atopic Dermatitis and Psoriasis at the Society for Investigative Dermatology’s Annual Meeting
May 10, 2022 DermTech Reinforces Longstanding Mission to Help Reduce Melanoma Deaths, Aligning with the Biden Administration’s Renewed ‘Cancer Moonshot’ Program
May 04, 2022 DermTech Kicks Off Second Annual #Stickit2Melanoma Campaign, Raising Awareness for Melanoma and the Importance of Skin Exams
May 03, 2022 DermTech Reports First-Quarter 2022 Financial Results; Company Affirms Full-Year 2022 Outlook
Apr 28, 2022 DermTech Announces Publication of New GvHD Clinical Research Conducted in Collaboration with Memorial Sloan Kettering Cancer Center
Apr 25, 2022 DermTech to Showcase DermTech Stratum, an Expanded Translational Medicine Service Offering, at San Diego’s Inaugural ‘Innovation Day’ Event
Mar 08, 2022 DermTech Study, “Cost-Benefit Analysis of the Pigmented Lesion Assay When Introduced into the Visual Assessment / Histopathology Pathway for Lesions Clinically Suspicious for Melanoma,” Published in SKIN: The Journal of Cutaneous Medicine
